摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde oxime | 860362-09-0

中文名称
——
中文别名
——
英文名称
1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde oxime
英文别名
7-azaindole-3-carboxaldehyde oxime;N-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylidene)hydroxylamine
1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde oxime化学式
CAS
860362-09-0
化学式
C8H7N3O
mdl
——
分子量
161.163
InChiKey
OLNLEHBKPXBJPF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188-190 °C(Solv: hexane (110-54-3))
  • 密度:
    1.39±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.3
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde oxime盐酸 作用下, 反应 0.75h, 以35%的产率得到1H-吡咯并[2,3-b]吡啶-3-甲胺
    参考文献:
    名称:
    Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum
    摘要:
    Sclerotinia sclerotiorum is a fungal pathogen, which causes stem rot in crucifer crops and in several other plant families resulting in enormous yield losses all over the world. Brassinin is a phytoalexin produced by crucifer plants as part of a general defense mechanism against pathogens and other forms of stress. To the great detriment of crucifers, some fungal pathogens, as for example S. sclerotiorum, can cletoxify brassinin. Detoxification of brassinin via glucosylation of the indole nitrogen is carried out by an inducible glucosyltransferase produced in S. sclcrotiorum. Because brassinin is a precursor of several phytoalexins active against S. sclcrotiorum, brassinin glucosyltransferase (BGT) is a potentially useful metabolic target to control S. sclerotiorum. Toward this end, we have designed, synthesized, and screened several brassinin analogues using both mycelial cultures and cell-free homogenates of S. sclerotiorum. A noticeable decrease in the rate of brassinin detoxification in cell cultures was observed in the presence of methyl (benzofuran-3-yl)methyl dithiocarbamate, methyl (benzofuran-2-yl)methyldithiocarbamate, methyl (indol-2-yl)methyldithiocarbamate, 3-phenylindole, 6-fluoro-3-phenylindole, and 5-fluorocamalexin. In addition, these compounds caused substantial inhibition of BGT activity (ca. 80%) in cell-free homogenates of S. sclerotiorum, while only brassinin and 3-phenylindole were transformed to the corresponding beta-D-1-glucopyranosyl products. These results indicate that, although many other glucosyltransferases appear to be produced by S. sclerotiorum in cell cultures, BGT is substrate specific. Overall these results show that selective and potent inhibitors of BGT can be developed. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.05.072
  • 作为产物:
    描述:
    7-氮杂吲哚-3-甲醛盐酸羟胺sodium carbonate 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以94%的产率得到1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde oxime
    参考文献:
    名称:
    Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum
    摘要:
    Sclerotinia sclerotiorum is a fungal pathogen, which causes stem rot in crucifer crops and in several other plant families resulting in enormous yield losses all over the world. Brassinin is a phytoalexin produced by crucifer plants as part of a general defense mechanism against pathogens and other forms of stress. To the great detriment of crucifers, some fungal pathogens, as for example S. sclerotiorum, can cletoxify brassinin. Detoxification of brassinin via glucosylation of the indole nitrogen is carried out by an inducible glucosyltransferase produced in S. sclcrotiorum. Because brassinin is a precursor of several phytoalexins active against S. sclcrotiorum, brassinin glucosyltransferase (BGT) is a potentially useful metabolic target to control S. sclerotiorum. Toward this end, we have designed, synthesized, and screened several brassinin analogues using both mycelial cultures and cell-free homogenates of S. sclerotiorum. A noticeable decrease in the rate of brassinin detoxification in cell cultures was observed in the presence of methyl (benzofuran-3-yl)methyl dithiocarbamate, methyl (benzofuran-2-yl)methyldithiocarbamate, methyl (indol-2-yl)methyldithiocarbamate, 3-phenylindole, 6-fluoro-3-phenylindole, and 5-fluorocamalexin. In addition, these compounds caused substantial inhibition of BGT activity (ca. 80%) in cell-free homogenates of S. sclerotiorum, while only brassinin and 3-phenylindole were transformed to the corresponding beta-D-1-glucopyranosyl products. These results indicate that, although many other glucosyltransferases appear to be produced by S. sclerotiorum in cell cultures, BGT is substrate specific. Overall these results show that selective and potent inhibitors of BGT can be developed. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.05.072
点击查看最新优质反应信息

文献信息

  • 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS
    申请人:Brough Paul
    公开号:US20100010037A1
    公开(公告)日:2010-01-14
    Compounds of formula (I) have HSP90 inhibitory activity: ring A is an aryl or heteroaryl ring or ring system; R 1 is hydrogen, fluoro, chloro, bromo, or a radical of formula (1A): —X-Alk 1 -(Z) m -(Alk 2 ) n -Q (IA) wherein X is a bond, —O—, —S—, —S(O)—, —SO 2 —, or —NH—, Z is —O—, —S—, —(C═O)—, —(C═S)—, —S(O)—, —SO 2 —, —NR A —, or, in either orientation —C(═O)O—, —C(═O)NR A —, —C(═S)NR A —, —SO 2 NR A —, —NR A C(═O)—, or —NR A SO 2 — wherein R A is hydrogen or C 1 -C 6 alkyl in which one or more hydrogens is optionally substituted by fluorine; Alk 1 and Alk 2 are optionally substituted divalent C 1 -C 3 alkylene or C 2 -C 3 alkenylene radicals, m and n are independently 0 or 1, and Q is hydrogen or an optionally substituted carbocyclic or heterocyclic radical; R 2 is cyano (—CN), fluoro, chloro, bromo, methyl, ethyl, —OH, —CH 2 OH, —C(═O)NH 2 , —C(═O)H, —C(═O)CH 3 , or —NH 2 ; R 3 and R 4 are independently selected from hydrogen, fluoro, chloro, bromo, cyano (—CN), C 1 -C 3 alkyl optionally substituted with one or more fluorine substituents, C 1 -C 3 alkoxy optionally substituted with one or more fluorine substituents, —CH═CH 2 , —C≡CH, cyclopropyl and —NH 2 , or R 3 and R 4 together represent methylenedioxy (—OCH 2 O—) or ethylenedioxy (—OCH 2 CH 2 O—) in either of which one or more hydrogens are optionally replaced by fluorine; S 1 is as defined in the description.
    公式(I)的化合物具有HSP90抑制活性:环A是芳基或杂环芳基环或环系;R1是氢,或式(1A)的基团:—X-Alk1-(Z)m-(Alk2)n-Q(IA),其中X是键,—O—,—S—,—S(O)—,—SO2—或—NH—,Z是—O—,—S—,—(C═O)—,—(C═S)—,—S(O)—,—SO2—,—NRA—或,以任一方向为—C(═O)O—,—C(═O)NRA—,—C(═S)NRA—,—SO2NRA—,—NRAC(═O)—或—NRASO2—,其中RA是氢或C1-C6烷基,其中一个或多个氢原子可以选择性地被取代;Alk1和Alk2是可选择性取代的二价C1-C3烷基或C2-C3烯基基团,m和n独立地为0或1,Q是氢或可选择性取代的碳环或杂环基团;R2是(—CN),,甲基,乙基,—OH,— OH,—C(═O)NH2,—C(═O)H,—C(═O)CH3或—NH2;R3和R4独立地选择自氢,(—CN),C1-C3烷基,可选择性地取代有一个或多个取代基的C1-C3烷氧基,—CH═CH2,—C≡CH,环丙基和—NH2,或R3和R4一起代表甲亚甲氧基(—O O—)或乙亚甲氧基(—O O—),其中一个或多个氢可以选择性地被取代;S1如描述中所定义。
  • Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines
    作者:Rajesh H. Bahekar、Mukul R. Jain、Pradip A. Jadav、Vijay M. Prajapati、Dipam N. Patel、Arun A. Gupta、Ajay Sharma、Robby Tom、Debdutta Bandyopadhya、Honey Modi、Pankaj R. Patel
    DOI:10.1016/j.bmc.2007.08.005
    日期:2007.11
    In the present investigation, two series of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines (2a-1) and thieno[2,3-b]pyridines (3a-1) were designed as analogs of BL 11282 (1). The in vitro glucose dependent insulinotropic activity of all the test compounds was evaluated using RIN5F cell based assay and all the test compounds showed glucose and concentration dependent insulin secretion. The in vivo antidiabetic activities of most potent compounds from each series (2c and 3c) were assessed in C57BL/6J mice. Compounds 2c and 3c showed dose dependent insulin secretion and significant glucose reduction in vivo. In general, compounds 2c and 3c were found to be equipotent at all the three different doses selected and with respect to BL 11282, both the test compounds were found to be more potent, at all the time points. (C) 2007 Elsevier Ltd. All rights reserved.
  • WO2008/25947
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 骆驼蓬酸 顺-六氢-1H-吡咯并[3,2-B]吡啶-4(2H)-羧酸叔丁基酯 螺哌啶-4,3’-3H吡咯并[2,3-b]吡啶-2’(1’H)-酮 螺[哌啶-4,3'-吡咯并[2,3-B]吡啶]-2'(1'H)-酮盐酸盐 莫西沙星杂质69 苹果酸法米替尼 苯乙胺,a,4-二甲基-b-苯基- 苄基-11氢吡咯并[3,4-B]吡啶 罗沙布林 甲基6-甲酰基-1-甲基-1H-吡咯并[3,2-b]吡啶-2-羧酸酯 甲基5-氰基-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 甲基4-溴-1H-吡咯并[2,3-B]吡啶-2-甲酸基酯 甲基1H-吡咯并[2,3-B]吡啶-5-甲酸酯 甲基-1-甲氧基-4-吡咯并[3,2-c]吡啶 甲基 5-硝基-1H-吡咯并[2,3-B]吡啶-2-羧酸 环戊二烯并[4,5]吡咯并[2,3-B]吡啶,5,6,7,8-四氢 氧代-(1H-吡咯并[2,3-b]吡啶-3-基)-乙酸甲酯 培西达替尼盐酸盐 培西达替尼 吲嗪 吲哚嗪-6-羧酸乙酯 吲哚嗪-3-甲腈 吲哚嗪-2-羧酸甲酯 吲哚嗪-2-羧酸 吡啶并[2,3-b]吡嗪-3(4H)-酮,2-(3-吡啶基甲基)-4-[3-[2-(5-嘧啶基)乙烯基]苯基]-,(E)- 叔丁基八氢-1H-吡咯并[2,3-c]吡啶-6-羧酸盐 叔丁基5-溴-7-氯-3-碘-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基5-溴-7-氯-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基3-甲酰基-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基3-(3-羟丙基-1-炔基)-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基(5-甲基-1H-吡咯并[2,3-b]吡啶-3-基)氨基甲酸酯 叔丁基((5-氟代-1H-吡咯并[2,3-b]吡啶-4-基)甲基氨基甲酸酯 叔-丁基3-碘-1H-吡咯并[2,3-c]吡啶-1-羧酸酯 反式-六氢-1H-吡咯并[3,4-C]吡啶-5(6H)-羧酸叔丁酯 化合物 T28221 八氢吡咯并[3.4-b]吡啶-1-羧酸叔丁酯 八氢吡咯并[3,4-b]吡啶 八氢-吡咯[3,4-C]吡啶-2-甲酸叔丁酯 八氢-6-(苯基甲基)-1H-吡咯并[3,4-b]吡啶-1-羧酸 1,1-二甲基乙酯 八氢-1H-吡咯并[3,4-C]吡啶 二苯基(吡咯并[2,3-b]吡啶-1-基)膦 二乙基1H-吡咯并[2,3B]吡啶-2,6-二甲酸基酯 乙基7-氯-3-甲基-1H-吡咯并[3,2-b]吡啶-2-甲酸基酯 乙基7-氮杂吲哚-4-羧酸酯 乙基4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 乙基3-氨基-2-吲嗪羧酸酯 乙基1-乙基-1H-吡咯并[3,2-c]吡啶-6-羧酸酯 中氮茚-7-羧酸甲酯 中氮茚-6-羧酸